Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Safety and efficacy of venglustat in GBA1-associated Parkinsons disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Early trial results In phase 2 trials, Retatrutide delivered impressive results: Mean weight reduction of up to ~17.5% at 24 weeks, rising to ~24.2% at 48 weeks in overweight/obese adults
This dual action could lead to even better glucose control and weight loss than either dulaglutide or semaglutide
It is not appropriate for everyone, and understanding who benefits most helps researchers make informed decisions about whether the added complexity and cost are justified
US$ 24.87
US$ 25.22
US$ 26.63
US$ 25.96
US$ 23.44
US$ 25.74
US$ 29.35
US$ 28.48
US$ 20.02
